MA (EU) number
(Invented) 
name
Strength
EU/1/13/904/004  Mirvaso 
3 mg/g 
Pharmaceutical 
Form
Gel 
Route of 
Administration
Cutaneous use 
Immediate Packaging
tube (PE/EAA copolymer/Alu/EAA 
copolymer/PE) 
Content 
(concentration)
2 g 
Pack 
size
1 tube 
EU/1/13/904/005  Mirvaso 
3 mg/g 
Gel 
Cutaneous use 
EU/1/13/904/006  Mirvaso 
3 mg/g 
Gel 
Cutaneous use 
EU/1/13/904/007  Mirvaso 
3 mg/g 
Gel 
Cutaneous use
EU/1/13/904/008
Mirvaso 
3 mg/g 
Gel 
Cutaneous use 
EU/1/13/904/009
Mirvaso 
3 mg/g 
Gel 
Cutaneous use 
tube (PE/EAA copolymer/Alu/EAA 
copolymer/PE) 
10 g 
tube (PE/EAA copolymer/Alu/EAA 
copolymer/PE) 
30 g 
Multidose container with airless 
pump (PP/TPO/HDPE) 
30 g 
tube (PE/PE/EEA 
copolymer/Alu/PE/PEHD+LLDPE)
10 g
tube (PE/PE/EEA 
copolymer/Alu/PE/PEHD+LLDPE)
30 g
1 tube 
1 tube 
1 pump 
1 tube
1 tube
1
